Business Context and Reporting Period
This Form 8-K was filed by Medical Transcription Billing, Corp. (MTBC) on December 11, 2017. The registrant is an emerging growth company incorporated in Delaware. The filing reports on a material definitive agreement entered into on December 7, 2017, regarding a public offering of preferred stock.
Key Financial Metrics
The filing details a capital raise rather than operational performance metrics. Key figures include:
- Securities Issued: 155,440 shares of 11% Series A Cumulative Redeemable Preferred Stock.
- Net Proceeds: Approximately $3.4 million after deducting placement agency fees and estimated offering expenses.
- Revenue, Profit, and Cash Flow: The filing text does not provide a clear value for current period revenue, profit, operating cash flow, or margins.
- Debt and Liquidity: Specific debt levels and liquidity ratios are not disclosed in this report.
Material Changes
The primary material change is the completion of a public offering of preferred stock. This transaction increases the company's equity capital by approximately $3.4 million. No comparative financial data or changes in operational metrics versus prior periods are provided in this document.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosures associated with the issuance of preferred stock. The transaction was executed pursuant to a Registration Statement on Form S-3 (File No. 333-210391). No unusual items or contingencies were reported in this specific filing.
Investor Verification Checklist
- Verify the terms of the 11% Series A Cumulative Redeemable Preferred Stock, including redemption rights and dividend obligations.
- Confirm the use of the $3.4 million in net proceeds as described in the accompanying press release (Exhibit 99.1).
- Review the Placement Agency Agreement (Exhibit 1.1) for any restrictive covenants or conditions.
- Check subsequent filings for the impact of this preferred stock issuance on the company's overall capital structure and liquidity.